Vietnam’s second COVID-19 vaccine candidate enters human trials
A ceremony was held at the Hanoi Medical University on January 21 to kick-start clinical trials of COVIVAC, Vietnam’s second COVID-19 vaccine candidate and developed based on the new highly-infectious coronavirus variants.
COVIVAC is Vietnam’s second COVID-19 vaccine candidate and developed based on the new highly-infectious coronavirus variants. (Photo: VNA)
Hanoi (VNA) - A ceremony was held at the Hanoi MedicalUniversity on January 21 to kick-start clinical trials of COVIVAC, Vietnam’ssecond COVID-19 vaccine candidate and developed based on the new highly-infectiouscoronavirus variants.
The home-grown vaccine has been developed by the Nha Trang-basedInstitute of Vaccines and Medical Biologicals (IVAC) and the Hanoi MedicalUniversity since last May, using primary chicken embryo cell culture, atechnique the institute used previously to successfully produce seasonal fluvaccines.
COVIVAC has undergone pre-clinical trials in India, the US, and Vietnam,said IVAC Director Dr Duong Huu Thai, adding that results showed that it satisfiesall conditions to be tested on humans.
The vaccine candidate demonstrated high immunogenicity duringpre-clinical trials. It was created based on studies of new SARS-CoV-2 strains,according to Dr Pham Van Tac, Director of the Ministry of Health’sAdministration of Science Technology and Training.
A ceremony is held at the Hanoi Medical University on January 21 to kick-start clinical trials of COVIVAC. (Photo: VNA)
“We can totally count on this vaccine candidate,” Tac said.
There will be two phases in the trial, with the first conducted on fivegroups of volunteers totalling 120 people. Each group will be given two shots28 days apart, with doses of either 1mcg, 3mcg, or 10mcg.
The volunteers, aged 18 to 59, has been recruited by the research team.
The first shot is scheduled to be injected at the Hanoi MedicalUniversity in February./.
Cambodia will receive 1 million doses of anti-COVID-19 vaccine developed by Sinopharm of China to vaccinate 500,000 people, Cambodian Prime Minister Hun Sen has announced via his Facebook account.
Prof. Dr. Huynh Thi Phuong Lien has been awarded with the title of “Hero of Labour in the “Doi Moi” (Renewal) Period” in recognition of her outstanding contributions to the development of the vaccine industry in Vietnam from 2009 – 2019.
Assistant Secretary General, Deputy Regional Director and Director for the Asia-Pacific of the UNDP Kanni Wignaraja has affirmed that the UNDP will continue assisting Asia-Pacific nations in overcoming the consequences of COVID-19 pandemic and fulfilling sustainable development goals (SDGs).
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
COVIVAC is Vietnam’s second COVID-19 vaccine candidate and developed based on the new highly-infectious coronavirus variants. (Photo: VNA)
A ceremony is held at the Hanoi Medical University on January 21 to kick-start clinical trials of COVIVAC. (Photo: VNA)
